These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 8755703

  • 1. A second dose of MMR vaccine for children in the United Kingdom.
    Commun Dis Rep CDR Wkly; 1996 Jul 26; 6(30):259. PubMed ID: 8755703
    [No Abstract] [Full Text] [Related]

  • 2. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC, Burgess MA, O'Brien ED.
    Commun Dis Intell; 1998 Aug 06; 22(8):159. PubMed ID: 9735551
    [No Abstract] [Full Text] [Related]

  • 3. Sentinel surveillance shows small decline in MMR coverage.
    Commun Dis Rep CDR Wkly; 1998 Sep 04; 8(36):317, 320. PubMed ID: 9782644
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE, Kumar ML, Whitwell JK, Staehle BO, Rome LP, Dinakar C, Hurni W, Nalin DR.
    Pediatr Infect Dis J; 1996 Aug 04; 15(8):687-92. PubMed ID: 8858673
    [Abstract] [Full Text] [Related]

  • 7. Serologic responses to measles, mumps, and rubella (MMR) vaccine in healthy infants: failure to respond to measles and mumps components may influence decisions on timing of the second dose of MMR.
    Mitchell LA, Tingle AJ, Décarie D, Lajeunesse C.
    Can J Public Health; 1998 Aug 04; 89(5):325-8. PubMed ID: 9813922
    [Abstract] [Full Text] [Related]

  • 8. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

  • 9. MMR vaccine--one year on.
    Walker D.
    Practitioner; 1990 May 22; 234(1489):550-2. PubMed ID: 2392406
    [No Abstract] [Full Text] [Related]

  • 10. Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme.
    Broliden K, Abreu ER, Arneborn M, Böttiger M.
    Vaccine; 1998 May 22; 16(2-3):323-7. PubMed ID: 9607050
    [Abstract] [Full Text] [Related]

  • 11. Expanded programme on immunization. Vaccine efficacy in a measles immunization programme.
    Wkly Epidemiol Rec; 1992 Jul 24; 67(30):224-7. PubMed ID: 1498025
    [No Abstract] [Full Text] [Related]

  • 12. Need for measles revaccination.
    John TJ.
    Indian Pediatr; 1998 Aug 24; 35(8):789-91. PubMed ID: 10216577
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P.
    Ann Ig; 1998 Aug 24; 10(1):19-24. PubMed ID: 9616974
    [No Abstract] [Full Text] [Related]

  • 15. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines.
    Miller E, Hill A, Morgan-Capner P, Forsey T, Rush M.
    Vaccine; 1995 Jun 24; 13(9):799-802. PubMed ID: 7483800
    [Abstract] [Full Text] [Related]

  • 16. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E, Tischer A.
    Gesundheitswesen; 1993 Jan 24; 55(1):38-9. PubMed ID: 8435543
    [Abstract] [Full Text] [Related]

  • 17. Measles, mumps, and rubella: recommendations for children/adolescents.
    Nurse Pract; 1996 Oct 24; 21(10):88, 91-2, 94. PubMed ID: 8895194
    [No Abstract] [Full Text] [Related]

  • 18. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
    Gatchalian S, Cordero-Yap L, Lu-Fong M, Soriano R, Ludan A, Chitour K, Bock HL.
    Southeast Asian J Trop Med Public Health; 1999 Sep 24; 30(3):511-7. PubMed ID: 10774661
    [Abstract] [Full Text] [Related]

  • 19. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
    Schettini F, Manzionna MM, De Mattia D, Amendola F, Di Bitonto G.
    Minerva Pediatr; 1989 Mar 24; 41(3):117-22. PubMed ID: 2747598
    [Abstract] [Full Text] [Related]

  • 20. Response to measles-mumps-rubella vaccine in children on dialysis.
    Schulman SL, Deforest A, Kaiser BA, Polinsky MS, Baluarte HJ.
    Pediatr Nephrol; 1992 Mar 24; 6(2):187-9. PubMed ID: 1571219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.